What is Implicity?
Implicity operates a sophisticated AI-driven platform designed to aggregate, normalize, and standardize data from implantable cardiac devices across all manufacturers. This technology is crucial for Independent Diagnostic Testing Facilities and cardiac electrophysiology centers worldwide, enabling them to deliver advanced, high-quality care to patients with connected CIEDs. The platform's ability to provide a unified view of patient data facilitates more proactive and effective treatment strategies.
How much funding has Implicity raised?
Implicity has raised a total of $23M across 1 funding round:
Series A
$23M
Series A (2022): $23M with participation from XAnge, Serena, Karista, Feedaxess, Bpifrance, and BNP Paribas Development
Key Investors in Implicity
XAnge
XAnge is a European early-stage venture capital firm with €700M AUM and over 20 years of experience, dedicated to empowering visionary founders from Seed to Series B with capital and expertise. The firm has supported more than 200 startups, achieving over 120 exits and backing 5 unicorns, while focusing on transformative value beyond capital.
Karista
Karista specializes in helping individuals find ideal home care or disability support services tailored to their specific needs and preferences. They offer an independent comparison service to assist clients in making informed choices. The company aims to connect clients with suitable care options, ensuring personalized support.
Bpifrance
Founded in 2012, based out of France, Bpifrance finances companies - at each stage of their development - with credit, guarantees and equity. Bpifrance supports them in their innovation projects and internationally. Bpifrance also ensures their export activity through a wide range of products.
What's next for Implicity?
The recent major strategic investment signals a strong vote of confidence in Implicity's technology and market position. This capital infusion is expected to fuel further development of its AI capabilities, expand its reach into new markets, and enhance its service offerings for healthcare providers. The company is poised to play an increasingly vital role in the remote patient monitoring landscape, driving innovation in cardiac care and improving patient outcomes through data-driven insights.
See full Implicity company page
